RT Book, Section
A1 Ursem, Carling
A1 McQuaid, Kenneth R.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193162277
T1 Esophageal Cancer
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193162277
RD 2024/10/04
AB Key  Clinical  Updates  in  Esophageal  CancerFor  patients  who  complete  neoadjuvant  chemoradiation  and  undergo  a  complete  resection  but  are  found  to  have  residual  cancer  in  the  resection  specimen,  a  year  of  adjuvant  immunotherapy  with  nivolumab  is  recommended.Ahmed  O  et  al.  Clin  Gastroenterol  Hepatol.  [PMID:  33813072]